Development of Microfluidic Technologies for Cell Processing and QC

Tuesday, 13 December 2022 at 12:30

Add to Calendar ▼2022-12-13 12:30:002022-12-13 13:30:00Europe/LondonDevelopment of Microfluidic Technologies for Cell Processing and QCLab-on-a-Chip and Microfluidics World Congress 2022 in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Quality control tests are essential for any cell therapy manufacturing process.  Quality control assays performed “in-line” or “at-line” allow much faster feedback loops in the manufacturing process, motivating a point-of-use approach.  Towards that end, Triple Ring Technologies developing user-friendly that leverage microscale phenomena to assess the quality of cell therapy manufacturing processes and products in a high-precision, high-throughput, and point-of-use manner. I shall share some of our work developing microfluidic cartridges integrated with optical imaging for on-chip multiplexed QC of critical cell samples.

Shaheen Jeeawoody, Senior Systems Integration Engineer, Triple Ring Technologies

Shaheen Jeeawoody

Shaheen Jeeawoody is a senior systems integration engineer at Triple Ring Technologies in Fremont, CA. Her expertise spans multiple areas across bioengineering, including systems engineering, medical devices, bioinstrumentation, microfluidics and bioMEMS, organ-on-a-chip platforms, and tissue engineering. During her Ph.D., Shaheen has designed, characterized, and expanded upon analytical assays to study previously-undetectable protein isoforms in arrays of single cells. These microfluidic technologies leverage the capabilities of both electrophoretic separations of proteins and immunoassay-based detection for improved analytical sensitivity and throughput, opening the door to highly-multiplexed data sets quantifying cellular and tissue heterogeneity. Shaheen received a Ph.D. from the UC Berkeley / UCSF joint graduate program in Bioengineering, for which she received a National Science Foundation Graduate Research Fellowship (GRFP) and a National Institutes of Health T32 Graduate Fellowship through the UC Berkeley Stem Cell Center. She also received a B.S. in Bioengineering from Stanford. Triple Ring Technologies is a co-development company that has worked with 400+ clients (including startups, well-established industry giants, and government agencies) to solve hard problems, launch breakthrough products, and create new businesses.